Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
14.76
+0.01 (0.07%)
Nov 22, 2024, 4:00 PM EST - Market closed
Oculis Holding AG Employees
Oculis Holding AG had 36 employees as of December 31, 2023. The number of employees increased by 8 or 28.57% compared to the previous year.
Employees
36
Change (1Y)
8
Growth (1Y)
28.57%
Revenue / Employee
$28,544
Profits / Employee
-$2,289,445
Market Cap
619.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| OrthoPediatrics | 247 |
| Simulations Plus | 247 |
| Omeros | 198 |
| EyePoint Pharmaceuticals | 121 |
| Stoke Therapeutics | 110 |
| CorMedix | 83 |
| Altimmune | 59 |
| Immunome | 55 |
OCS News
- 10 days ago - Oculis to Present at the Stifel 2024 Healthcare Conference - GlobeNewsWire
- 16 days ago - Oculis Reports Q3 2024 Financial Results and Provides Company Updates - GlobeNewsWire
- 4 weeks ago - Oculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program Committees - GlobeNewsWire
- 5 weeks ago - Oculis' DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024 - GlobeNewsWire
- 6 weeks ago - Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board - Business Wire
- 7 weeks ago - Oculis Announces Appointment of Daniel S. Char as Chief Legal Officer - GlobeNewsWire
- 2 months ago - Oculis and EURETINA Announce the Winner of the Inaugural Ramin Tadayoni Award - GlobeNewsWire
- 3 months ago - Oculis to Present at Upcoming September Investor Conferences - GlobeNewsWire